Ocugen Inc
Change company Symbol lookup
Select an option...
OCGN Ocugen Inc
BBWI Bath & Body Works Inc
OPI Office Properties Income Trust
DHC Diversified Healthcare Trust
GNL-A Global Net Lease Inc
PRS Prudential Financial Inc
LEN Lennar Corp
LEG Leggett & Platt Inc
LDP Cohen & Steers Limited Duration Preferred and Income Fund, Inc
LADR Ladder Capital Corp
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Growth
Company profile

Ocugen, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. The Company's technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. It is developing COVAXIN, which is a whole-virion inactivated intramuscular COVID-19 vaccine candidate for the North American market. It is also developing a inhaled mucosal vaccine platform, which includes OCU500, a bivalent COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and bivalent COVID-19 vaccine. Its modifier gene therapy platform is focused on addressing various retinal diseases, including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), and Stargardt disease, with a single mutation-agnostic therapy.

Closing Price
$0.4724
Day's Change
0.0207 (4.58%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.4724
Day's Low
0.451
Volume
(Light)
Volume:
7,201,891

10-day average volume:
12,746,067
7,201,891

Upcoming Events

OCGN's fiscal year ends in December
There are no upcoming events for OCGN

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
May 5, 2023Q1 2023 Earnings Release-$0.07-$0.11 to -$0.10-$0.09
February 28, 2023Q4 2022 Earnings Release-$0.10-$0.11 to -$0.06-$0.07
November 8, 2022Q3 2022 Earnings Release-$0.10-$0.12 to -$0.06-$0.05
August 5, 2022Q2 2022 Earnings Release-$0.09-$0.10 to -$0.06-$0.13

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.